300
Participants
Start Date
March 13, 2023
Primary Completion Date
March 14, 2026
Study Completion Date
April 28, 2026
Intrauterine administration of PBMC immunomodulated with IFNt
Standard density gradient centrifugation will be performed to obtain autologous PBMC from patients' peripheral blood (9 ml). Isolated cells will be suspended in RPMI 1640 supplemented with 10% HSA (human serum albumin) and incubated in the presence of 500 IU/ml IFNt for 24 h at 37˚C. The cultured cell suspension will be introduced into the uterine cavity via a catheter.
RECRUITING
Nadezhda Women's Health Hospital, Sofia
Nadezhda Women's Health Hospital
OTHER